NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268958. A total of 4 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -99.9% | 100 | -99.8% | 0.00% | – |
| Q4 2021 | $727,000 | -4.3% | 53,800 | +27.2% | 0.00% | – |
| Q3 2021 | $760,000 | +4.7% | 42,300 | 0.0% | 0.00% | – |
| Q2 2021 | $726,000 | -14.2% | 42,300 | 0.0% | 0.00% | – |
| Q1 2021 | $846,000 | +147.4% | 42,300 | +125.0% | 0.00% | – |
| Q3 2019 | $342,000 | -47.5% | 18,800 | 0.0% | 0.00% | – |
| Q2 2019 | $652,000 | -61.0% | 18,800 | -62.2% | 0.00% | – |
| Q1 2019 | $1,673,000 | +27.2% | 49,800 | +24.5% | 0.00% | – |
| Q4 2018 | $1,315,000 | -98.1% | 40,000 | -97.2% | 0.00% | -100.0% |
| Q2 2018 | $68,880,000 | +1923.5% | 1,410,600 | +2374.7% | 0.01% | +1300.0% |
| Q4 2017 | $3,404,000 | – | 57,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 900 | $941,000 | 0.06% |
| GROUP ONE TRADING, L.P. | 189,000 | $1,975,000 | 0.04% |
| Citadel Advisors | 27,400 | $286,000 | 0.00% |